Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
docetaxel (taxotere) (1 trial)
pi-88 (1 trial)
prednisone (meticorten) (1 trial)
Prostatic Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (3 total)